Top Stock Performers This Week Jan 20-24, 2025 Key Highlights

Which stocks performed the best this week? Discover PL, VSAT, FPH and more key highlights

Jan 25 2025

This week, a few stocks grabbed my attention for all the right reasons—solid fundamentals, exciting news, and strong momentum. If you're looking to keep your finger on the pulse of the market, these are definitely the ones you’ll want to watch as the best stock performers that captured the spotlight.

Planet Labs PBC

Planet Labs $PL emerged as a best stock contender this week, with its shares surging nearly 7% during Thursday’s session. The Earth-observing satellite company secured a $200M contract under the Luno B IDIQ program, which further solidifies its growth trajectory.

Adding to its momentum, Cantor initiated coverage on PL, emphasizing its strategic position in the rapidly expanding space sector. Its also upgraded to a Strong Buy, reflecting growing confidence in its earnings potential. While options activity on Friday signaled speculative interest, the question remains: can PL sustain its rally, or will volatility take over?

Viasat Inc.

Viasat $VSAT claimed its place as one of the best stock performers this week, skyrocketing 29%. The stock’s meteoric rise was fueled by its $4.8B NASA contract to enhance direct-to-Earth communication capabilities. This contract underscores Viasat’s leadership in satellite communications and its ability to capitalize on rising demand for advanced aerospace technology.

Five Point Holdings

Five Point Holdings $FPH surged over 30% this week, cementing its status as one of the best stock performers in the real estate sector. Strong quarterly earnings, with a GAAP EPS of $0.65 and revenue of $159.79M, drove this rally.

Analysts suggest FPH recent focus on fundamentals has reignited investor interest, making it a compelling choice for those seeking undervalued assets. As the real estate market stabilizes, FPH has the potential to maintain its momentum, solidifying its position as a best stock pick for long-term.

Schrödinger Inc.

Schrödinger $SDGR soared 14.1% this week, driven by excitement surrounding its AI-powered drug discovery platform. As a leader in integrating artificial intelligence into healthcare, SDGR represents a unique opportunity for growth.

With broader enthusiasm for AI applications in biotech, SDGR is seen by many as a best stock in the biotech-AI space. However, its valuation may face scrutiny if earnings fail to meet high expectations.

Evolus Inc.

Evolus $EOLS delivered a standout performance this week, rallying over 16% pre-market on Tuesday. Known for its rivalry with Botox-maker AbbVie, EOLS announced robust Q4 revenue of $79M and bullish guidance for 2025.

These updates solidified its position as a best stock in the performance beauty market. While some analysts remain cautious about market saturation, the company’s strong growth story continues to attract attention.

Unlock Exclusive Stock Insights!

Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.

Signup now for FREE and stay ahead of the market curve!

Why Join?

Find out what 10,000+ subscribers already know.

Real-time insights for informed decisions.

Limited slots available, SignUp Now!

Signup Now!

Please note that the article should not be considered as investment advice or marketing, and it does not take into account the personal data and requirements of any individual. It is not a substitute for the reader's own judgment, and it should not be considered as advice or recommendation for buying or selling any securities or financial products.